Background
Thalassemia syndromes, caused by impaired α- and/or β-globin chain synthesis, together with sickle cell disease represent the most common human Mendelian disorders. There are an estimated ~ 56,000 annual births globally with severe thalassemia (hemoglobin [Hb] Bart’s hydrops fetalis, Hb H disease, β-thalassemia major, and Hb E/β-thalassemia) [
1], though the burden of all clinically significant thalassemia disease likely far exceeds this estimate. Due to increasing international migration, the epidemiology of hemoglobin disorders is changing rapidly, and the resulting new challenges posed to health services have been recognized in Europe and the United States [
2‐
4]. Southeast Asia (SEA) is severely affected by thalassemia syndromes [
5], with high frequencies of both α- and β-thalassemia, including Hb E (β26 Glu➔Lys), a structural variant that reduces β-globin expression (Table
1).
Table 1
Carrier rates (in %) for common hemoglobin disorders in Southeast Asiaa
| 0 | 4.3 | 2–22.7 | 0–3.7 |
Cambodia | 1 | 15.5 | 2.8 | 10–54 |
Indonesia | < 1 | 3–20 | 3 | 1–33 |
| 8.7–13.9 | 11–17.7 | 3.5–5 | 22.9– > 30 |
Malaysia | 4.5 | 16 | 4.5 | 1–3 |
Myanmar | NA | 10 | 1–5.3 | 4–48 |
Philippines | 5 | 2.2 | 1 | NA |
Singapore | 2–3 | 1–3 | 0.93 | 0.64 |
Thailand | 2.2–9 | 8–30 | 1–3 | 10–50 |
Vietnam | NA | 3.5 | 4 | 10–20 |
Thailand has one of the highest burdens of thalassemia in the world, with ~ 15 million carriers and 50,000 pregnancies at risk annually for severe thalassemia [
11]. Thailand is also one of the few SEA countries with effective severe thalassemia prevention and control policies, focusing on public education, prenatal screening, and prenatal diagnosis. This has led to a decreased incidence of severe thalassemia syndromes, including Hb Bart’s hydrops fetalis [
11]. Concurrently, Thailand’s relatively prosperous and stable economy has encouraged increasing migration from neighboring countries, with 2.4 million migrant workers from Myanmar, Cambodia, and Laos [
12,
13]. These three neighboring countries are also estimated to have a high prevalence of thalassemia and Hb E (Table
1). However, they do not have national thalassemia education, screening, or counseling programs in place, and data on the incidence of severe thalassemia syndromes are limited due to lack of routine screening [
14]. With increasing intra-regional migration, the lack of access to thalassemia-related services among migrant populations in Thailand not only hinders early diagnosis and treatment but also potentially undermines the Thai thalassemia program’s long-term success. Anecdotally, a rise in the number of births affected by severe thalassemia among migrant couples has been observed (V. Viprakasit, personal communication, November 1, 2017).
Addressing the issue of thalassemia in migrant populations is therefore of utmost importance but fraught with challenges. Migrant workers are often low-skilled, enter through irregular channels, and have limited or no access to healthcare. There are also large populations of asylum seekers and refugees from Myanmar and other neighboring countries who have crossed the border into Thailand irregularly and reside in refugee camps and border towns. The lack of epidemiological data regarding disease burden in different migrant populations hinders policymakers’ abilities to weigh the social benefit and economic cost of implementing thalassemia programs. Additionally, knowledge gaps and cultural differences are known barriers to the uptake of screening and the effectiveness of thalassemia prevention efforts [
15‐
17], yet few studies have examined knowledge, attitudes, and health-seeking behaviors among SEA migrants. How best to engage migrants in thalassemia education and screening and whether screening is feasible and acceptable to migrant populations must be explored.
We developed demographic and knowledge, attitudes, and practices (KAP) surveys to identify potential barriers to thalassemia screening among Myanmar and Cambodian migrant workers residing in Chonburi, an industrial province within the Eastern Economic Corredor (EEC), a major growing economic region in Thailand and home to one of the largest migrant worker populations in the country. We hypothesized that migrant subjects would have less awareness of thalassemia compared to Thai subjects and that knowledge would correlate with attitudes towards thalassemia screening and prevention. Furthermore, we performed comprehensive thalassemia testing to demonstrate the disease burden and assess the feasibility and acceptability of thalassemia screening in migrants. Novel insights from this study may inform regional migrant health policy and improve thalassemia education, prevention, and care for migrant populations globally.
Results
There were 197 Thai, 119 Myanmar, and 176 Cambodian (492 total) subjects (Fig.
1 and Table
3). The median age was similar among all groups, but the Cambodian cohort had more males. Over 70% of migrants reported some proficiency in Thai. Around 60 and 27% of Thai space obtained secondary and higher education, respectively, compared to 35 and 3% of Myanmar and 30 and 1% of Cambodians. Cambodians had the highest proportion of subjects (~ 27%) with no formal education. Migrants were more often married than Thai subjects but reported similar numbers of children (Table
3). Marriage to an individual with a different nationality was reported by ~ 5% of migrants (with 8/11 having a Thai spouse), while Thai subjects reported no inter-group marriages.
Table 3
Characteristics of the study population
Median Age (IQR), years | 32 (24–40) | 29 (24–36) | 30 (27–37) |
Gender |
Male (%) | 71 (36.0) | 43 (36.4) | 100 (56.8) |
Female (%) | 126 (64.0) | 75 (63.6) | 76 (43.2) |
Languages Spokena |
Thai (%) | 196 (99.5) | 73 (61.3) | 133 (76.0) |
Burmese (%) | 0 | 109 (91.6) | 7 (4.1) |
Khmer (%) | 0 | 2 (1.7) | 168 (97.1) |
English (%) | 49 (24.9) | 0 | 3 (1.7) |
Mon (%) | 1 (0.5) | 7 (5.9) | 0 |
Karen (%) | 0 | 9 (7.6) | 0 |
Highest Level of Education Achieved |
None (%) | 2 (1.0) | 18 (15.4) | 48 (27.4) |
Primary, 1–6 (%) | 22 (11.3) | 53 (45.3) | 74 (42.3) |
Secondary, 7–9 (%) | 58 (29.9) | 29 (24.8) | 41 (23.4) |
Secondary 10–12 (%) | 58 (29.9) | 12 (10.3) | 11 (6.3) |
Vocational (%) | 24 (12.4) | 0 | 0 |
Bachelor’s degree and above (%) | 28 (14.4) | 3 (2.6) | 1 (0.6) |
Work Sector |
Fishery (%) | 2 (1.1) | 0 | 2 (1.2) |
Manufacturing (%) | 63 (34.6) | 40 (36.0) | 75 (43.1) |
Domestic (%) | 40 (22.0) | 37 (33.3) | 13 (7.5) |
Construction (%) | 5 (2.8) | 8 (7.2) | 43 (24.7) |
Other (%)b | 72 (39.6) | 26 (23.4) | 41 (23.6) |
Median Duration in Thailand (IQR), years | NA | 6 (4.25–10) | 5 (3–6) |
Median Number of Times Moved (IQR) | NA | 0 (0–2) | 0 (0–2) |
Health Registration |
First time (%) | NA | 28 (25.0) | 42 (24.1) |
Renewal (%) | NA | 84 (75.0) | 132 (75.9) |
Marital Status |
Single (%) | 65 (33.9) | 32 (27.1) | 39 (22.7) |
Married (%) | 114 (59.4) | 83 (70.3) | 127 (73.8) |
Divorced (%) | 13 (6.8) | 3 (2.5) | 6 (3.5) |
Nationality of Spouse if Married |
Thai (%) | 111 (100) | 3 (3.6) | 5 (4.0) |
Myanmar (%) | 0 | 75 (93.8) | 2 (1.7) |
Cambodian (%) | 0 | 1 (1.3) | 113 (94.2) |
Median Number of Children (IQR) | 2 (1–2) | 1 (0–2) | 2 (1–2) |
Myanmar subjects reported residing in Thailand for longer than Cambodians. Nevertheless, transience was surprisingly low, with the majority having never moved within Thailand. Within work sectors (Table
3), more Thai subjects reported holding white-collar jobs (e.g., managerial or sales), while migrants largely held blue-collar or informal sector jobs. Three-quarters of migrant workers had previously undergone health registration, while one-quarter reported registering for the first time (i.e., were likely undocumented or “unregistered”).
Healthcare utilization is lower among migrants
Most subjects preferred to first seek care from a doctor or medical facility. Drug stores were the next most preferred contact, while few reported seeking care from traditional healers (Table
4). Thai and Cambodian subjects relied heavily on public health insurance. Migrants generally used cash more often than Thai subjects to pay for health care (~ 36% vs. 11%). Thai subjects had a higher median number of doctor visits within the past 1 year compared to migrants (Table
4). Unregistered status was associated with shorter length of residence (median 4.0 years, vs. 5.1 years for registered migrants).
Table 4
Comparison of thalassemia-related health literacy and health behaviors among Thai, Myanmar, and Cambodian subjects
Health-seeking Behaviors |
First Point of Contact When Sick |
Drug store (%) | 71 (37.6) | 47 (40.2) | 77 (44.8) |
Doctor (%) | 115 (60.9) | 65 (55.6) | 88 (51.2) |
Traditional healer (%) | 1 (0.5) | 3 (2.6) | 3 (1.7) |
Other (%)a | 2 (1.1) | 2 (1.7) | 4 (2.3) |
Median Number of Doctor Visits in 1 year (IQR) | 1 (0–3) | 0 (0–1) | 0 (0–2) |
Method of Payment for Healthcare |
Public Insurance (%) | 82 (44.1) | 37 (31.4) | 80 (46.2) |
Employer Insurance (%) | 52 (28.0) | 29 (24.6) | 30 (17.3) |
Private Insurance (%) | 18 (9.7) | 1 (0.9) | 1 (0.6) |
Cash (%) | 19 (10.2) | 49 (41.5) | 53 (30.6) |
Other (%)b | 15 (8.1) | 2 (1.7) | 9 (5.2) |
Want to test self for thalassemia (%)c | 25 (62.5) | 67 (61.5) | 147 (86.5) |
Want to test baby for thalassemia (%)c | 29 (72.5) | 77 (70.6) | 145 (86.8) |
Want to test partner for thalassemia (%)c | 29 (78.4) | 81 (74.3) | 150 (88.8) |
Best Method for Thalassemia Education |
Consultation with doctor (%) | 26 (68.4) | 93 (86.9) | 144 (84.2) |
Brochure (%) | 1 (2.6) | 8 (7.5) | 10 (5.9) |
Employer workshop (%) | 1 (2.6) | 1 (0.9) | 2 (1.2) |
Government workshop (%) | 5 (13.2) | 2 (1.9) | 5 (2.9) |
Other (%)d | 5 (13.2) | 3 (2.8) | 10 (5.9) |
Thalassemia-related Health Literacy |
Aware of Anemia (%) | 151 (80.3) | 23 (20.0) | 24 (13.7) |
Aware of Thalassemia (%) | 156 (79.6) | 8 (6.8) | 4 (2.3) |
Personal History of: |
Anemia (%) | 31 (16.0) | 7 (6.0) | 7 (4.1) |
Thalassemia (%) | 12 (6.2) | 0 | 3 (1.7) |
Transfusion (%) | 13 (6.7) | 1 (0.9) | 10 (5.8) |
Miscarriage (%) | 15 (7.9) | 8 (6.9) | 11 (6.4) |
Family History of: |
Anemia (%) | 34 (17.4) | 4 (3.5) | 9 (5.2) |
Thalassemia (%) | 11 (5.7) | 1 (0.9) | 1 (0.6) |
Transfusion (%) | 15 (7.8) | 2 (1.7) | 6 (3.5) |
Miscarriage (%) | 17 (8.9) | 5 (4.4) | 8 (4.6) |
Migrants have very low thalassemia awareness but show interest in thalassemia screening
Most Thai subjects were aware of anemia and thalassemia (both ~ 80%). In contrast, a minority of Myanmar and Cambodian migrants were aware of anemia (20 and 13.7%), and few were aware of thalassemia (6.8 and 2.3%). Thai subjects also reported more personal and family history of anemia, thalassemia, and blood transfusion compared to migrants (Table
4).
Subjects without awareness of thalassemia were briefly informed about thalassemia and asked if they were interested in thalassemia screening. Most expressed interest, with Cambodians showing greatest interest. All groups preferred to receive thalassemia education through consultations with a doctor, with migrants showing a stronger preference (Table
4).
Factors associated with thalassemia awareness
Subgroup analysis of factors predicting thalassemia awareness in migrants revealed an association with longer residence duration in Thailand (median 13.1 vs. 5.0 years; Z = 3.82, p = 0.0002). Within the Thai subgroup, females had 2.12 times higher odds (95% CI 1.05–4.29; p = 0.03) of being aware of thalassemia compared to males, and those with secondary education had 2.69 times higher odds (95% CI 1.08–6.71, p = 0.03) than those less educated. Among both Thai and migrant subjects, awareness of anemia strongly predicted thalassemia awareness (OR = 11.07 [95% CI 4.82–25.44, p < 0.0001] and 18.87 [95% CI 4.89, 72.84, p < 0.0001], respectively).
Comparison of knowledge, attitudes, and practices of migrant vs. Thai subjects
Thalassemia knowledge was lower for migrants compared to Thai subjects (median knowledge score of 7 (IQR 6–8) vs. 8 (IQR 7–10), Z = -3.10,
p = 0.002, Table
5). Only 27.3% of migrants knew that thalassemia was common in Asia, vs. 72.3% of Thai subjects. Compared to 54.2% of Thai subjects, 90.9% of migrants thought a thalassemia carrier could develop thalassemia major. However, both groups held key misconceptions: 32.9% of Thai and 45.4% of migrant subjects believed that thalassemia was an infectious disease, and 39.3 and 54.5%, respectively, believed that thalassemia was curable with a pill rather than a chronic disease. Understanding of carrier status was poor; most Thai and migrant subjects believed that non-carrier couples could give birth to a child with thalassemia and that thalassemia carriers require blood transfusions. Subjects without secondary education had lower knowledge levels than those with secondary education (median score of 6 (IQR 6–9) vs. 8 (IQR 8–10), Z = 3.30,
p = 0.001). Age, gender, and health-seeking behaviors did not correlate with knowledge scores.
Table 5
Individual question responses and cumulative knowledge and attitude scores from the KAP survey
Knowledge Questions (% Correct) |
1. Thalassemia is blood disease. | 94.8% | 72.7% |
2. Thalassemia is cause of anemia. | 87.7% | 81.8% |
3. Thalassemia is rare in Asia. | 72.3% | 27.3% |
4. Thalassemia is infectious disease. | 67.1% | 54.6% |
5. Thalassemia is inherited disease. | 91.0% | 72.7% |
6. Normal parents can have affected child. | 25.8% | 9.1% |
7. Carrier parents at risk for affected pregnancy. | 70.3% | 63.6% |
8. Blood test can be done. | 97.4% | 100.0% |
9. Thalassemia carrier requires transfusions. | 42.6% | 36.4% |
10. Thalassemia major requires transfusions. | 86.5% | 90.9% |
11. A carrier can develop thalassemia major. | 45.8% | 9.1% |
12. Can cure thalassemia with pill. | 60.7% | 45.5% |
Median Knowledge Score (IQR) a | 8 (7–10) | 7 (6–8) |
Attitude Questions (Median, IQR) |
13. Thalassemia should be prevented. | 4 (4–5) | 5 (5–5) |
14. Child with thalassemia is burden. | 3 (2–4) | 4 (2–5) |
15. Child with thalassemia is blessing. | 1 (1–2) | 1 (1–2) |
16. Want to know if having baby affected. | 4 (4–5) | 5 (4–5) |
17. Would get tested during pregnancy. | 5 (4–5) | 5 (5–5) |
18. Want partner tested during pregnancy. | 5 (4–5) | 5 (3–5) |
19. Have children with partner if both carriers. | 3 (2–4) | 1 (1–3) |
20. Would not want to know if baby affected. | 2 (1–4) | 1 (1–1) |
21. Testing during pregnancy not useful. | 3 (1–4) | 1 (1–5) |
22. Not have children with partner if both carriers. | 3 (2–5) | 1 (1–5) |
23. Would end pregnancy for thalassemia. | 3 (2–4) | 2 (1–5) |
24. Disagree with ending pregnancy. | 4 (3–4) | 5 (4–5) |
25. Would not prevent birth of affected baby. | 3 (3–4) | 5 (1–5) |
26. Better to end pregnancy than let child suffer. | 4 (3–4) | 3 (1–5) |
Median Attitude Score (IQR) b | 3.4 (3.2–3.8) | 3.7 (3.3–3.9) |
Practice Questions (N, %) |
27. Subject tested for thalassemia. | 72 (46.8) | 3 (27.3) |
28. Partner tested for thalassemia. | 59 (38.3) | 1 (9.1) |
29. Had prenatal diagnosis (PND). | 53 (68.0) | 2 (66.7) |
30. PND showed affected baby. | 4 (7.6) | 1 (50.0) |
31. Plan to have more children. | 94 (62.7) | 8 (72.7) |
Attitude scores were considered a proxy for subjects’ attitudes towards thalassemia prevention and control, with a score of 5 indicating strong support and 1 indicating strong opposition. The median attitude score was 3.4 (IQR 3.2–3.8) for Thai subjects and 3.7 (IQR 3.3–3.9) for migrants, suggesting that subjects leaned towards supporting thalassemia prevention overall. Examining individual questions, Thai and migrant subjects agreed that thalassemia should be prevented, that having a child with thalassemia was more of a burden than a blessing, and that they preferred to know whether their pregnancy was affected by thalassemia and would test themselves and their partners (Table
5). Paradoxically, migrants expressed a stronger desire to know whether a pregnancy was affected by thalassemia (Questions 16 and 20) but held more negative attitudes toward actual termination of pregnancy (Questions 23–26, Table
5). No correlation between knowledge and attitude scores was found. Cronbach’s ⍺ for internal reliability of the survey tool was 0.66 for knowledge questions and 0.67 for attitude questions.
Finally, Thai subjects and their partners reported having been tested for thalassemia more often than migrants (Table
5). Of those tested, around two-thirds reported undergoing prenatal diagnosis (PND), leading to a diagnosis of severe thalassemia in one migrant pregnancy and four Thai pregnancies; the decision for termination of pregnancy was not captured. Most subjects in both groups planned to have more children in the future (Table
5).
Thalassemia is prevalent in migrants, and screening is feasible and acceptable
Of the 300 migrants surveyed, 286 subjects (95.3%) underwent phlebotomy and had residual blood samples available for thalassemia testing, demonstrating the feasibility of obtaining blood samples for thalassemia testing during the health registration process. Of the 286 subjects, 277 (96.9%) consented to thalassemia testing, suggesting that thalassemia testing is acceptable to migrants. We identified at least one ⍺- or β-globin mutation in 53.4% (148/277) of migrants, compared to 43.8% (540/1232) of Thai subjects in a separate cohort (Table
6).
Table 6
Allele frequencies of the most common hemoglobin variants identified in Thai vs. migrant cohorts
Deletional ⍺+-thalassemia | 0.088 | 0.186 | 0.183 | 0.184 |
⍺3.7 | 0.080 | 0.182 | 0.179 | 0.181 |
-⍺4.2 | 0.008 | 0.004 | 0.003 | 0.004 |
Deletional ⍺0- thalassemia | 0.022 | 0.004 | 0.013 | 0.009 |
- -SEA | 0.022 | 0.004 | 0.010 | 0.007 |
- -THAI | 0 | 0 | 0.003 | 0.002 |
Non-deletional ⍺+- thalassemia | 0.026 | 0 | 0.003 | 0.002 |
Hb Constant Spring | 0.024 | 0 | 0 | 0 |
Hb Pakse | 0.001 | 0 | 0.003 | 0.002 |
Hb E | 0.127 | 0.058 | 0.192 | 0.134 |
β-thalassemia (β0 or β+) | 0.007 | 0.025 | 0.003 | 0.013 |
βIVSI-1 | 0.001 | 0.012 | 0.003 | 0.007 |
βCD17 | 0.002 | 0 | 0 | 0 |
βCD71/72 | 0.0004 | 0.004 | 0 | 0.002 |
βCD41/42 | 0.001 | 0 | 0 | 0 |
The most common variants identified were -⍺
3.7 and Hb E. The Myanmar and Cambodian cohorts had a higher frequency of deletional ⍺
+-thalassemia alleles (0.186 and 0.183, respectively) compared to the Thai cohort (0.088). Hb E allele frequency was highest amongst Cambodians (0.192), and β-thalassemia allele frequency highest amongst Myanmar (0.025). Non-deletional ⍺-globin variants (Hb Constant Spring, Hb Pakse, and Hb Quang Sze) and deletional ⍺
0-thalassemia variants (− −
SEA and - -
THAI) were more frequent in the Thai cohort. Around 15% of Cambodians were double heterozygous carriers of ⍺- and β-globin variants due to high frequencies of Hb E and -⍺
3.7, compared to 4–5% of the Thai and Myanmar cohorts (Table
7). Severe thalassemia disease syndromes (11, Hb H disease; 1, Hb E/β-thalassemia) were only identified in the Thai cohort. Rare ⍺- and β-globin variants were found in Thai (Hb Westmead, Hb Quang Sze, and Hb D) and migrant (Hb Showa-Yakushiji) cohorts (Table
7).
Table 7
⍺- and β-globin genotypes identified in Thai and migrant cohorts in Chonburi, Thailand
Carriers of ⍺-globin variant | -⍺3.7/⍺⍺ | 126 | 10.2 | 34 | 28.1 | 30 | 19.2 | 64 | 23.1 |
-⍺4.2/⍺⍺ | 13 | 1.1 | 1 | 0.8 | 0 | 0 | 1 | 0.4 |
-⍺3.7/−⍺3.7 | 4 | 0.3 | 2 | 1.7 | 1 | 0.6 | 3 | 1.1 |
-⍺3.7/−⍺4.2 | 1 | 0.1 | 0 | 0 | 1 | 0.6 | 1 | 0.4 |
-⍺3.7/⍺CS⍺ | 8 | 0.6 | 0 | 0 | 0 | 0 | 0 | 0 |
- -SEA/⍺⍺ | 34 | 2.8 | 1 | 0.8 | 2 | 1.3 | 3 | 1.1 |
⍺CS⍺/⍺⍺ | 35 | 2.8 | 0 | 0 | 0 | 0 | 0 | 0 |
⍺PS⍺/⍺⍺ | 1 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 |
⍺QZ⍺/⍺⍺ | 1 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 223 | 18.1 | 38 | 31.4 | 34 | 21.8 | 72 | 26.0 |
Carriers of β-globin variant | βE/β | 186 | 15.1 | 10 | 8.3 | 29 | 18.6 | 39 | 14.1 |
βD/β | 3 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 |
βIVSI-1/β | 1 | 0.1 | 1 | 0.8 | 1 | 0.6 | 2 | 0.7 |
βIVSII-654/β | 1 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 |
βCD17/β | 5 | 0.4 | 0 | 0 | 0 | 0 | 0 | 0 |
βCD71/72/β | 1 | 0.1 | 1 | 0.8 | 0 | 0 | 1 | 0.4 |
βCD41/42/β | 1 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 |
βCD27/28/β | 1 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 |
β−28/β | 1 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 |
β-3.48/β | 2 | 0.2 | 1 | 0.8 | 0 | 0 | 1 | 0.4 |
Total | 202 | 16.4 | 13 | 10.7 | 30 | 19.2 | 43 | 15.5 |
Double heterozygous carriers | -⍺3.7/⍺⍺ + βE/β | 28 | 2.3 | 2 | 1.7 | 18 | 11.5 | 20 | 7.2 |
-⍺4.2/⍺⍺ + βE/β | 6 | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 |
-⍺3.7/−⍺3.7 + βE/β | 5 | 0.4 | 0 | 0 | 2 | 1.3 | 2 | 0.7 |
- -SEA/⍺⍺ + βE/β | 8 | 0.6 | 0 | 0 | 1 | 0.6 | 1 | 0.4 |
- -THAI/⍺⍺ + βE/β | 0 | 0 | 0 | 0 | 1 | 0.6 | 1 | 0.4 |
⍺CS⍺/⍺⍺ + βE/β | 5 | 0.4 | 0 | 0 | 0 | 0 | 0 | 0 |
⍺PS⍺/⍺⍺ + βE/β | 0 | 0 | 0 | 0 | 1 | 0.6 | 1 | 0.4 |
-⍺3.7/⍺⍺ + βD/β | 1 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 |
-⍺3.7/⍺⍺ + βCD41/42/β | 1 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 |
-⍺3.7/⍺⍺ + βCD35/β | 1 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 |
-⍺3.7/⍺⍺ + β−28/β | 1 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 |
-⍺3.7/⍺⍺ + βIVSI-1/β | 0 | 0 | 2 | 0.8 | 0 | 0 | 2 | 0.7 |
-⍺3.7/⍺⍺ + βCD110/β a | 0 | 0 | 1 | 0.8 | 0 | 0 | 1 | 0.4 |
⍺CS⍺/⍺⍺ + βIVSI-1/β | 1 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 57 | 4.6 | 5 | 4.1 | 23 | 14.7 | 28 | 10.1 |
Homozygous Hb E (with/without ⍺-thalassemia) | βE/βE | 25 | 2.0 | 0 | 0 | 3 | 0.2 | 3 | 1.1 |
-⍺3.7/⍺⍺ + βE/βE | 4 | 0.3 | 1 | 0.1 | 1 | 0.1 | 2 | 0.7 |
-⍺3.7/−⍺3.7 + βE/βE | 1 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 |
⍺CS⍺/⍺⍺ + βE/βE | 3 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 33 | 2.7 | 1 | 0.8 | 4 | 2.6 | 5 | 1.8 |
Hb H disease (with/without ⍺-thalassemia) | - -SEA/−⍺3.7 | 6 | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 |
- -SEA/⍺CS⍺ | 3 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 |
- -SEA/⍺CS⍺ + βE/β | 1 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 |
- -SEA/⍺WM⍺ + βE/β | 1 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 11 | 0.9 | 0 | 0 | 0 | 0 | 0 | 0 |
Compound heterozygous β-thalassemia | βCD41/42/βE | 1 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 |
Other ⍺-thalassemia diseases | ⍺CS⍺/⍺CS⍺ | 1 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 |
⍺CS⍺/⍺PS⍺ + βE/β | 1 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 |
⍺ triplication | 5 | 0.4 | NT | NT | NT | NT | NT | NT |
⍺ triplication + βE/β | 6 | 0.5 | NT | NT | NT | NT | NT | NT |
Total | 13 | 1.1 | 0 | 0 | 0 | 0 | 0 | 0 |
Any thalassemia carrier | Total | 540 | 43.8 | 57 | 47.1 | 91 | 58.3 | 148 | 53.4 |
Higher rate of births with severe thalassemia among migrant populations
Based on prevalence estimates from this study, the projected rate of births affected by all thalassemia diseases is 11.193/1000 births/year in migrants and 9.167/1000 births/year in the Thai population. Projected birth rates are highest for Hb Bart’s hydrops fetalis and Hb E/β-thalassemia in the Thai population and for homozygous β-thalassemia in the Myanmar migrant population (Table
8). Projected Hb H disease birth rates are similar in Thai and Cambodian migrant populations but lower in Myanmar migrants (4.885 and 4.759 vs. 1.525/1000 births/year, respectively). The projected number of newborns in the Thai population with Hb Bart’s hydrops fetalis and Hb H disease, adjusted for annual birth rate, is comparable to previous estimates [
27], but the number of Thai newborns affected by β-thalassemia syndromes is higher than prior estimates [
31] (Table
8).
Table 8
Comparison of estimates of affected newborns with thalassemia disease for Thai populations and migrant workers
Hb Bart’s hydrops fetalis |
• Affected newborns (cases/1000 birth/year) | 0.462 | N/A | N/A | 0.017 | 0.164 |
• Affected newborns in Thailanda (cases/year) | 335 | 423 (CI: 184–761) | 833 | < 1 (0.18) | < 1 (0.23) |
Hb H disease (all) |
• Affected newborns (cases/1000 birth/year) | 4.885 | N/A | N/A | 1.525 | 4.759 |
• Affected newborns in Thailanda (cases/year) | 3540 | 3172 | 5600 | 16 | 7 |
• Deletional Hb H disease (cases/year) | 2742 | 2674 (CI:1296–4491) | N/A | 16 | 7 |
• Non-deletional Hb H disease (cases/year) | 798 | 498 (CI:237–947) | N/A | 0 | 0 (0.1) |
Homozygous β-thalassemia |
• Affected newborns (cases/1000 birth/year) | 0.202 | N/A | N/A | 0.615 | 0.010 |
• Affected newborns in Thailanda (cases/year) | 146 | N/A | 207 | 7 | < 1 (0.01) |
Hb E/β-thalassemia |
• Affected newborns (cases/1000 birth/year) | 3.618 | N/A | N/A | 2.872 | 1.231 |
• Affected newborns in Thailanda (cases/year) | 2622 | N/A | 3213 | 31 | 2 |
• Hb E/β+-thalassemia (cases/year) | 1126 | N/A | N/A | 5 | 0 |
• Hb E/β0-thalassemia (cases/year) | 1496 | N/A | N/A | 26 | 2 |
Discussion
This is the first study characterizing thalassemia knowledge, attitudes, and health-related behaviors of migrant populations in Thailand and one of few studies examining beliefs and perceptions surrounding thalassemia in SEA. Through comprehensive thalassemia testing, we identified a higher proportion of thalassemia carriers and higher allele frequencies of some globin variants in a migrant cohort compared to a Thai cohort. Furthermore, using prevalence estimates, we found a higher projected rate of births affected by severe thalassemia in the migrant cohort compared to the Thai cohort, highlighting the significant disease burden in migrants that needs to be addressed.
We hypothesized existence of a significant gap in thalassemia awareness between Thai and migrant subjects; indeed, only 4% of migrants vs. 80% of Thai subjects had heard of thalassemia. Thalassemia awareness was associated with female gender and achieving secondary education in the Thai cohort. Our migrant cohort, on average, was more male and less educated. Consistent with migrants’ length of residence in Thailand being a proxy for linguistic integration and exposure to mass media, migrants aware of thalassemia had resided in Thailand longer. Additional potential factors leading to increased awareness in long-term migrant residents include increased likelihood of interaction with the healthcare system and larger social networks, in which knowledge of thalassemia may spread by word of mouth.
A study of thalassemia awareness among Italians vs. Italian-Americans also found a large knowledge gap (85% vs. 19%), attributed to exposure to thalassemia education and screening in Italy and the lack of such programs in the United States [
23]. A similar disparity in exposure may underlie our findings, as Thailand’s thalassemia prevention and control programs only offer education, outreach, and free prenatal screening to Thai citizens and are not accessible to migrants. Education is an effective approach to lowering the burden of thalassemia [
23,
32], and as such, bolstering education efforts in migrant communities could be a rational initial approach to addressing this awareness gap. However, educational efforts may be hindered by sociocultural barriers.
Education level and literacy were lower for migrant than Thai subjects in this study. Awareness of thalassemia was correlated with attainment of secondary education, as well as with awareness of hematological disorders in general, a measure of health literacy. Migrants also demonstrated a lower understanding of the genetic inheritance of thalassemia. A study in Yangon, Myanmar, found that even among mothers of children receiving regular care for thalassemia, only 18–28% had an understanding of genetic inheritance [
19]. Therefore, effective thalassemia programs for migrant populations should also emphasize genetic education and counseling. In addition, Thai females were more aware of thalassemia than males, possibly related to Thailand’s prenatal approach to thalassemia prevention, providing women with more exposure through antenatal care clinics. For male migrant workers, alternative settings for screening and education should be explored.
Our study also highlights the significant structural barriers faced by migrant populations. One-quarter of our migrant cohort was unregistered, i.e., without legal documentation or access to public health insurance, potentially influencing their health seeking behaviors. Migrants were more likely to pay for healthcare with cash and less likely to have multiple types of insurance compared to Thai subjects, likely leading to higher out-of-pocket costs and lower healthcare utilization. Cost of thalassemia testing was a commonly raised concern among migrants, underscoring the need for a government-sponsored program for thalassemia prevention for migrants, similar to that for Thai citizens.
Other structural barriers related to employment, transportation, and lack of interpreters for migrants were frequently encountered during this study. Subjects undergoing thalassemia testing were offered a return of results through either domestic mail or in-person pick-up at LCH, as well as free thalassemia genetic counseling at LCH. The vast majority of migrants expressed interest in learning their thalassemia carrier status and requested the return of results but declined to return for counseling due to concerns over missing work or finding transportation. Despite having translated study documents to Thai, Burmese, and Khmer, we faced tremendous language barriers due to poor literacy among migrants, as well as the limited availability and quality of interpreters, which likely impacted subjects’ comprehension of more complex or inverted survey items (e.g., Questions 19 and 22, Table
5). Addressing structural barriers hindering the delivery of thalassemia prevention and care to migrants may require concurrent changes in immigration and employment policies, particularly as half of the migrant population in Thailand may be unregistered [
33].
Additionally, the KAP survey revealed important misconceptions and beliefs that may reduce the acceptance of thalassemia screening. A large percentage of migrants believed thalassemia to be an infectious disease; correction of this and other misconceptions is required to prevent stigmatization of patients and carriers. Most migrants failed to identify thalassemia as a serious chronic condition and a common disease in Asia, which may detract from the perceived importance and urgency of screening. The fact that many Thai subjects held these same misconceptions highlights existing gaps in Thailand’s thalassemia education program that should be addressed.
All nationalities, in particular Cambodians, expressed a strong interest in the concept of thalassemia screening. However, migrants expressed more negative attitudes towards pregnancy termination, which might preclude the prenatal approach to thalassemia prevention in migrants. The surveys were not designed to elucidate reasons underlying migrants’ attitudes towards pregnancy termination; these themes should be explored in greater depth using qualitative methods, such as in-depth interviews and focus group discussions. On the other hand, our study had extremely high uptake (96.9%) of thalassemia screening by healthy migrant subjects, strongly suggesting that carrier screening would be acceptable to migrants.
Our health registration-based approach to thalassemia screening represents a unique and particularly efficient means of recruiting both documented and undocumented migrants. We found that public hospitals were a feasible, convenient setting for performing thalassemia screening but not for the return of results. An alternative setting that overcomes some structural barriers is the workplace, though privacy concerns and the willingness of employers to participate would need to be considered. Our study design has some limitations; survey results and thalassemia allele frequencies obtained from migrant workers presenting to LCH may not be representative of other migrant populations in Thailand. Indeed, we previously demonstrated spatial specificity in the gene frequency of ⍺-thalassemia in Thailand [
27]. A similar geographic limitation may exist for the Thai community cohort undergoing thalassemia testing. The Thai cohort presenting to LCH is likely representative of the majority of the Thai population, which utilizes public health services due to the availability of universal health coverage in Thailand. However, individuals using the private health sector may differ in socioeconomic status and may not be represented in our cohorts. Additionally, due to the extremely low level of thalassemia awareness among migrants, only 11 migrant subjects completed the KAP survey, compared to 155 Thai subjects. The limited KAP survey data from migrants made drawing comparisons challenging and further subset analyses impossible. Ideally, our findings would be confirmed using a larger representative sample of migrants, employing either a multicenter approach or with comparisons to SEA migrant populations residing in other host countries.
Nevertheless, this study highlights the dramatic gap in thalassemia awareness between Thai citizens and migrants and the urgent need for public educational interventions accessible to migrants. Furthermore, we developed a multilingual KAP survey with face validity and acceptable reliability for assessing thalassemia knowledge and attitudes across three different nationalities (see Additional file
1). This thalassemia-specific KAP survey should be further validated in future studies for use as a multinational tool in SEA populations worldwide.
Finally, our data confirm the high prevalence of thalassemia among migrants in Thailand, laying the foundation for additional epidemiological and cost-effectiveness studies needed to inform future policy decisions surrounding thalassemia prevention and control. The projected annual number of migrant newborns affected by severe thalassemia is likely an underestimate, due to unregistered migrant populations being unaccounted for in official migration statistics, demonstrating the need for regularization of the migrant workforce to create effective public health policies.
Conclusions
In this study, we developed a knowledge, attitudes, and practices (KAP) survey focused on thalassemia screening and validated the survey in healthy Myanmar, Cambodian, and Thai populations. We also offered comprehensive thalassemia testing to all migrant subjects and found that thalassemia is prevalent among Myanmar and Cambodian migrants and that nearly all migrants were willing to undergo thalassemia screening. However, we identified an extreme lack of awareness and understanding of thalassemia in migrant compared to Thai populations, as well as identified key misconceptions in both migrant and Thai populations that need to be addressed. Based on the KAP survey results, we conclude that lack of awareness of thalassemia is a prominent obstacle to thalassemia screening in migrant populations in Thailand and that public education efforts tailored to migrant populations are desperately needed. The negative attitudes towards termination of pregnancy among migrants suggest that Thailand’s prenatal approach to thalassemia screening may not be optimal for migrant populations and that other potential screening approaches should be explored. Indeed, we found carrier screening among migrant workers to be highly feasible and acceptable. Furthermore, the high frequencies of thalassemia variants identified in our migrant cohort argue strongly for the inclusion of migrant populations in thalassemia prevention and control policies in Thailand as well as regionally.
With increasing economic integration and cooperation among the ASEAN (Association of Southeast Asian Nations) member countries, intra-regional migration will continue to grow. The scientific community, healthcare providers, and policymakers must recognize the challenges posed by migration to regional thalassemia prevention and control and respond accordingly. Concerted efforts should be made not only to establish regional thalassemia screening programs and registries but also to extend thalassemia services to migrants within the region. With continued investigation into knowledge, cultural, and structural barriers to thalassemia prevention in migrant populations, we may begin to create a global solution for the growing public health problem of thalassemia.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.